Federal Actos lawsuits to a single judge in Louisiana Group

(PRWEB) 4 January 2012 On 28 December 2011, the U.S. District Court for the Western District of Louisiana agreed the assignment of all federal Actos ...


(PRWEB) 4 January 2012

On 28 December 2011, the U.S. District Court for the Western District of Louisiana agreed the assignment of all federal Actos cases honor Rebecca F. Doherty. As a result, more than 100 lawsuits alleging plaintiffs developed bladder cancer while or after taking Actos will be transferred to the Western District of Louisiana at this time. I have no doubt, to increase this number significantly because consumers are still learning the link between Actos and bladder cancer, said attorney David Ennis & Ennis, PA

In August plaintiffs with pending lawsuits against Japanese companies, Takeda Pharmaceuticals America, Inc. (Takeda), the manufacturer of Actos, to transmit a request for the 11 pending actions, and all subsequent actions Actos injury to a single judge for investigation procedures. The consolidation document avoids duplication and conflicting decisions, but also potentially save reports.

Actos, pioglitazone as the only ingredient that has been linked to increased risk of bladder cancer. In June, the U.S. Food and Drug Administration (FDA) has required added warnings on the label Actos indicating that the drug’s risk of bladder cancer (bladder tumors) if for more than a year increase lasted. Moreover, now the newly updated drug label recommends that health care providers should not use pioglitazone in patients with active bladder cancer and Pioglitazone should be used with caution in patients with a history of bladder cancer.

Takeda and Eli Lilly & Company jointly promoted Actos assumed in the U.S. since its introduction in 1999, but from 2006, Takeda exclusively of all marketing and sales activities for Actos. In 2008, with the knowledge of the risk in the development of bladder cancer, being associated with long-term Actos, Takeda achieved its marketing goal by Actos the tenth best-selling medication in the U.S., all U.S. citizens during placement using Actos the risk of developing bladder cancer, say the complaints. In addition, during the year ended 31 Of March 2010 Actos sales of 4.6 billion U.S. dollars, making it Takeda’s best-selling drug, according to BusinessWeek.

For those who take Actos, bladder cancer symptoms may include blood in the urine, pain during urination, frequent small amounts of urination, frequent urinary tract infections, lower back pain and abdominal back pain.


has

If you or a loved one from bladder cancer or bladder tumors suffered after taking Actos, fill out a form to MedWatch http://www.fda.gov, so the FDA is aware of the side effect. Then they seek the opinion of an experienced lawyer to explore your legal rights.

Ennis & P. ​​A. offers free nationwide confidential consultations for patients who are taking or have taken Actos, Actoplus or Duetact taken and suffer these symptoms by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case score sheet.

& Ennis, PA is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington DC that their practice is concentrated in the mass torts and represents individuals against pharmaceutical companies and medical device manufacturers.

& Ennis, PA has been representing clients individually since 1986 and has recovered for his clients over $ 100 million in settlements.

& Ennis, PA is also investigating cases, Accutane, Avandia, Fosamax, Transvaginal Mesh Devices, Paxil, Zoloft, Prozac, DePuy Hip Recall, Hip Recall room, Depakote, Reglan, SJS / Dilantin, Yaz, Yasmin and Ocella Birth Control Pills.


Remember

the law limits the time in which you file a claim, so do not wait to explore your legal rights. Call toll-free 1-800-856-6405 today or visit http://www.ennislaw.com.

# # #

clear = “all”

Leave a Reply